Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Investing.com - RBC Capital has reiterated an Outperform rating on Ingram Micro (NYSE:INGM) with a price target of $25.00. Currently trading at $21.70, the stock has shown strong momentum with a 37.62% gain over the past six months. InvestingPro analysis suggests the stock is slightly undervalued based on its proprietary Fair Value model.
The firm expects Ingram Micro to report quarterly results in line with expectations, with revenues likely reaching the upper end of the company’s guidance range.
RBC Capital attributes the anticipated performance to high single-digit growth in PCs and notebooks, supported by ongoing refresh cycles and Windows end-of-life transitions, though these tailwinds are moderating.
The firm projects sequential improvement in gross margins as previous headwinds related to asset sales will not recur, though product, customer, and geographic mix issues continue to pressure margins.
RBC Capital also notes that a ransomware attack affecting Ingram Micro in early July could potentially provide upside to revenue growth due to its timing.
In other recent news, Ingram Micro Holding Ltd reported its second-quarter 2025 earnings, which showed a mixed performance. The company posted an earnings per share (EPS) of $0.61, missing the forecasted $0.71, resulting in a 14.08% negative surprise. Despite this, Ingram Micro’s revenue saw a year-over-year increase of 10.9%, reaching $12.79 billion. This earnings miss has led to some concerns among investors. The company did not provide additional guidance or updates on future expectations. These developments are part of the latest updates for Ingram Micro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.